Gene therapy is an experimental treatment that involves introducing genetic material into a person?s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a ?vector.? The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy. This report contains market size and forecasts of Gene Therapy in global, including the following market information:
Global Gene Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Gene Therapy market was valued at US$ 7282.5 million in 2022 and is projected to reach US$ 37570 million by 2029, at a CAGR of 26.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.
In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
We surveyed the Gene Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Gene Therapy Market Segment Percentages, by Type, 2022 (%)
Viral Gene Therapy
Non-Viral Gene Therapy
Global Gene Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Gene Therapy Market Segment Percentages, by Application, 2022 (%)
Neurological Diseases
Cancer
Other
Global Gene Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Gene Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Therapy, market overview.
Chapter 2: Global Gene Therapy market size in revenue.
Chapter 3: Detailed analysis of Gene Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Therapy Overall Market Size
2.1 Global Gene Therapy Market Size: 2022 VS 2029
2.2 Global Gene Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Therapy Players in Global Market
3.2 Top Global Gene Therapy Companies Ranked by Revenue
3.3 Global Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy Players in Global Market
3.6.1 List of Global Tier 1 Gene Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene Therapy Market Size Markets, 2022 & 2029
4.1.2 Viral Gene Therapy
4.1.3 Non-Viral Gene Therapy
4.2 By Type - Global Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Gene Therapy Revenue, 2018-2023
4.2.2 By Type - Global Gene Therapy Revenue, 2024-2029
4.2.3 By Type - Global Gene Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Therapy Market Size, 2022 & 2029
5.1.2 Neurological Diseases
5.1.3 Cancer
5.1.4 Other
5.2 By Application - Global Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Gene Therapy Revenue, 2018-2023
5.2.2 By Application - Global Gene Therapy Revenue, 2024-2029
5.2.3 By Application - Global Gene Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Gene Therapy Market Size, 2022 & 2029
6.2 By Region - Global Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Gene Therapy Revenue, 2018-2023
6.2.2 By Region - Global Gene Therapy Revenue, 2024-2029
6.2.3 By Region - Global Gene Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Gene Therapy Revenue, 2018-2029
6.3.2 US Gene Therapy Market Size, 2018-2029
6.3.3 Canada Gene Therapy Market Size, 2018-2029
6.3.4 Mexico Gene Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Gene Therapy Revenue, 2018-2029
6.4.2 Germany Gene Therapy Market Size, 2018-2029
6.4.3 France Gene Therapy Market Size, 2018-2029
6.4.4 U.K. Gene Therapy Market Size, 2018-2029
6.4.5 Italy Gene Therapy Market Size, 2018-2029
6.4.6 Russia Gene Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Gene Therapy Market Size, 2018-2029
6.4.8 Benelux Gene Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Gene Therapy Revenue, 2018-2029
6.5.2 China Gene Therapy Market Size, 2018-2029
6.5.3 Japan Gene Therapy Market Size, 2018-2029
6.5.4 South Korea Gene Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Gene Therapy Market Size, 2018-2029
6.5.6 India Gene Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Gene Therapy Revenue, 2018-2029
6.6.2 Brazil Gene Therapy Market Size, 2018-2029
6.6.3 Argentina Gene Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Therapy Revenue, 2018-2029
6.7.2 Turkey Gene Therapy Market Size, 2018-2029
6.7.3 Israel Gene Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Gene Therapy Market Size, 2018-2029
6.7.5 UAE Gene Therapy Market Size, 2018-2029
7 Gene Therapy Companies Profiles
7.1 Biogen
7.1.1 Biogen Company Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Gene Therapy Major Product Offerings
7.1.4 Biogen Gene Therapy Revenue in Global Market (2018-2023)
7.1.5 Biogen Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Gene Therapy Major Product Offerings
7.2.4 Novartis Gene Therapy Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Gilead Sciences
7.3.1 Gilead Sciences Company Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Gene Therapy Major Product Offerings
7.3.4 Gilead Sciences Gene Therapy Revenue in Global Market (2018-2023)
7.3.5 Gilead Sciences Key News & Latest Developments
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Company Summary
7.4.2 Sarepta Therapeutics Business Overview
7.4.3 Sarepta Therapeutics Gene Therapy Major Product Offerings
7.4.4 Sarepta Therapeutics Gene Therapy Revenue in Global Market (2018-2023)
7.4.5 Sarepta Therapeutics Key News & Latest Developments
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Company Summary
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Gene Therapy Major Product Offerings
7.5.4 Alnylam Pharmaceuticals Gene Therapy Revenue in Global Market (2018-2023)
7.5.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Gene Therapy Major Product Offerings
7.6.4 Amgen Gene Therapy Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Company Summary
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Gene Therapy Major Product Offerings
7.7.4 Spark Therapeutics Gene Therapy Revenue in Global Market (2018-2023)
7.7.5 Spark Therapeutics Key News & Latest Developments
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Company Summary
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Gene Therapy Major Product Offerings
7.8.4 Akcea Therapeutics Gene Therapy Revenue in Global Market (2018-2023)
7.8.5 Akcea Therapeutics Key News & Latest Developments
7.9 bluebird bio
7.9.1 bluebird bio Company Summary
7.9.2 bluebird bio Business Overview
7.9.3 bluebird bio Gene Therapy Major Product Offerings
7.9.4 bluebird bio Gene Therapy Revenue in Global Market (2018-2023)
7.9.5 bluebird bio Key News & Latest Developments
7.10 Sunway Biotech
7.10.1 Sunway Biotech Company Summary
7.10.2 Sunway Biotech Business Overview
7.10.3 Sunway Biotech Gene Therapy Major Product Offerings
7.10.4 Sunway Biotech Gene Therapy Revenue in Global Market (2018-2023)
7.10.5 Sunway Biotech Key News & Latest Developments
7.11 SIBIONO
7.11.1 SIBIONO Company Summary
7.11.2 SIBIONO Business Overview
7.11.3 SIBIONO Gene Therapy Major Product Offerings
7.11.4 SIBIONO Gene Therapy Revenue in Global Market (2018-2023)
7.11.5 SIBIONO Key News & Latest Developments
7.12 AnGes
7.12.1 AnGes Company Summary
7.12.2 AnGes Business Overview
7.12.3 AnGes Gene Therapy Major Product Offerings
7.12.4 AnGes Gene Therapy Revenue in Global Market (2018-2023)
7.12.5 AnGes Key News & Latest Developments
7.13 Orchard Therapeutics
7.13.1 Orchard Therapeutics Company Summary
7.13.2 Orchard Therapeutics Business Overview
7.13.3 Orchard Therapeutics Gene Therapy Major Product Offerings
7.13.4 Orchard Therapeutics Gene Therapy Revenue in Global Market (2018-2023)
7.13.5 Orchard Therapeutics Key News & Latest Developments
7.14 Human Stem Cells Institute
7.14.1 Human Stem Cells Institute Company Summary
7.14.2 Human Stem Cells Institute Business Overview
7.14.3 Human Stem Cells Institute Gene Therapy Major Product Offerings
7.14.4 Human Stem Cells Institute Gene Therapy Revenue in Global Market (2018-2023)
7.14.5 Human Stem Cells Institute Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gene Therapy Market Opportunities & Trends in Global Market
Table 2. Gene Therapy Market Drivers in Global Market
Table 3. Gene Therapy Market Restraints in Global Market
Table 4. Key Players of Gene Therapy in Global Market
Table 5. Top Gene Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gene Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gene Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gene Therapy Product Type
Table 9. List of Global Tier 1 Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Gene Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gene Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Gene Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gene Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Gene Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gene Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Biogen Company Summary
Table 31. Biogen Gene Therapy Product Offerings
Table 32. Biogen Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Biogen Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Gene Therapy Product Offerings
Table 36. Novartis Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Gilead Sciences Company Summary
Table 39. Gilead Sciences Gene Therapy Product Offerings
Table 40. Gilead Sciences Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Gilead Sciences Key News & Latest Developments
Table 42. Sarepta Therapeutics Company Summary
Table 43. Sarepta Therapeutics Gene Therapy Product Offerings
Table 44. Sarepta Therapeutics Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Sarepta Therapeutics Key News & Latest Developments
Table 46. Alnylam Pharmaceuticals Company Summary
Table 47. Alnylam Pharmaceuticals Gene Therapy Product Offerings
Table 48. Alnylam Pharmaceuticals Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Alnylam Pharmaceuticals Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Gene Therapy Product Offerings
Table 52. Amgen Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Spark Therapeutics Company Summary
Table 55. Spark Therapeutics Gene Therapy Product Offerings
Table 56. Spark Therapeutics Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Spark Therapeutics Key News & Latest Developments
Table 58. Akcea Therapeutics Company Summary
Table 59. Akcea Therapeutics Gene Therapy Product Offerings
Table 60. Akcea Therapeutics Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Akcea Therapeutics Key News & Latest Developments
Table 62. bluebird bio Company Summary
Table 63. bluebird bio Gene Therapy Product Offerings
Table 64. bluebird bio Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. bluebird bio Key News & Latest Developments
Table 66. Sunway Biotech Company Summary
Table 67. Sunway Biotech Gene Therapy Product Offerings
Table 68. Sunway Biotech Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Sunway Biotech Key News & Latest Developments
Table 70. SIBIONO Company Summary
Table 71. SIBIONO Gene Therapy Product Offerings
Table 72. SIBIONO Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. SIBIONO Key News & Latest Developments
Table 74. AnGes Company Summary
Table 75. AnGes Gene Therapy Product Offerings
Table 76. AnGes Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. AnGes Key News & Latest Developments
Table 78. Orchard Therapeutics Company Summary
Table 79. Orchard Therapeutics Gene Therapy Product Offerings
Table 80. Orchard Therapeutics Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Orchard Therapeutics Key News & Latest Developments
Table 82. Human Stem Cells Institute Company Summary
Table 83. Human Stem Cells Institute Gene Therapy Product Offerings
Table 84. Human Stem Cells Institute Gene Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Human Stem Cells Institute Key News & Latest Developments
List of Figures
Figure 1. Gene Therapy Segment by Type in 2022
Figure 2. Gene Therapy Segment by Application in 2022
Figure 3. Global Gene Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gene Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gene Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy Revenue in 2022
Figure 8. By Type - Global Gene Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Gene Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Gene Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Gene Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Gene Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Gene Therapy Revenue Market Share, 2018-2029
Figure 16. US Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Gene Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Gene Therapy Revenue Market Share, 2018-2029
Figure 28. China Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Gene Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Gene Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Biogen Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Gilead Sciences Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sarepta Therapeutics Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Alnylam Pharmaceuticals Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Spark Therapeutics Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Akcea Therapeutics Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. bluebird bio Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sunway Biotech Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. SIBIONO Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. AnGes Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Orchard Therapeutics Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Human Stem Cells Institute Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
